Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 20/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27504654 | 0.88 | PDE5A (0.76) | PDE5A | |
| SCHEMBL27447976 | 0.88 | PDE5A (0.83) | PDE5A | |
| SCHEMBL27504950 | 0.88 | PDE5A (0.85) | PDE5A | |
| Hydrochloric Acid SCHEMBL6595391 | 0.87 | PDE5A (0.83) | PDE5A | |
| Hydrochloric Acid SCHEMBL6597649 | 0.87 | PDE5A (0.85) | PDE5A | |
| Hydrochloric Acid SCHEMBL6598895 | 0.87 | PDE5A (1.00) | PDE5A | |
| SCHEMBL6598334 | 0.85 | PDE5A (0.84) | PDE5A | |
| Hydrochloric Acid SCHEMBL6596617 | 0.85 | PDE5A (0.84) | PDE5A | |
| SCHEMBL6596543 | 0.84 | PDE5A (1.00) | PDE5A | |
| Hydrochloric Acid SCHEMBL6593234 | 0.83 | PDE5A (1.00) | PDE5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6288064-B1 | PHOSPHODIESTERASE INHIBITORS; PHTHALAZINE DERIVATIVES | EISAI CO., LTD. (JP) | 2001-09-11 | — | — | US | claimed |
| US-6218392-B1 | FOR THERAPY AND PROPHYLAXIS OF ISCHEMIC HEART DISEASES SUCH AS ANGINA PECTORIS, MYOCARDIAL INFARCT AND CHRONIC AND ACUTE CARDIAC FAILURE, PULMONARY HYPERTENSION, ARTERIOSCLEROSIS AND BRONCHIAL ASTHMA | EISAI CO., LTD. (JP) | 2001-04-17 | — | — | US | claimed |
| EP-0920868-A1 | REMEDY FOR ERECTION FAILURE COMPRISING FUSED PYRIDAZINE COMPOUND | Eisai Co., Ltd. (JP) | 1999-06-09 | — | — | EP | claimed |
| CN-1151136-C | Condensed pyridazine compound | ������������ʽ���� | 2004-05-26 | — | — | CN | disclosed |
| EP-0722936-B1 | FUSED PYRIDAZINE COMPOUND | EISAI CO LTD (JP) | 2004-05-19 | — | — | EP | disclosed |
| US-6218392-B1 | FOR THERAPY AND PROPHYLAXIS OF ISCHEMIC HEART DISEASES SUCH AS ANGINA PECTORIS, MYOCARDIAL INFARCT AND CHRONIC AND ACUTE CARDIAC FAILURE, PULMONARY HYPERTENSION, ARTERIOSCLEROSIS AND BRONCHIAL ASTHMA | EISAI CO., LTD. (JP) | 2001-04-17 | — | — | US | disclosed |
| US-5849741-A | Fused pyridazine compounds | EISAI CO., LTD. (JP) | 1998-12-15 | — | — | US | disclosed |
| CN-1135210-A | Fused pyridazine compound | EISAI CO LTD (JP) | 1996-11-06 | — | — | CN | disclosed |
| EP-0722936-A1 | FUSED PYRIDAZINE COMPOUND | Eisai Co., Ltd. (JP) | 1996-07-24 | — | — | EP | disclosed |